(Stroke. 1999;30:1110-1117.)
© 1999 American Heart Association, Inc.
Original Contributions |
From Columbia University, College of Physicians and Surgeons, New York, NY.
Correspondence to Dr David J. Pinsky, Columbia University, Department of Medicine, PH 10 Stem, 630 W 168th St, New York, NY 10032. E-mail djp5{at}columbia.edu
Background and PurposeNeutrophil (PMN) recruitment mediated by increased expression of intercellular adhesion molecule-1 expression (ICAM-1, CD54) in the cerebral microvasculature contributes to the pathogenesis of tissue injury in stroke. However, studies using blocking antibodies against the common ß2-integrin subunit on the PMN, the counterligand for ICAM-1 (CD18), have demonstrated equivocal efficacy. The current study tested the hypothesis that mice deficient in CD18 would be protected in the setting of reperfused but not nonreperfused stroke.
MethodsTwo groups of mice were studied, those whose PMNs could express CD18 (CD18 +/+) and those mice hypomorphic for the CD-18 gene (CD18 -/-). PMNs obtained from CD18 -/- or CD18 +/+ mice were fluorescently labeled and tested for binding to murine brain endothelial monolayers. Using a murine model of focal cerebral ischemia in which an occluding suture placed in the middle cerebral artery (MCA) is removed after 45 minutes (transient ischemia, reperfused stroke) or left in place (permanent ischemia, nonreperfused stroke), cerebral infarct volumes (% ipsilateral hemisphere by TTC staining), cerebral blood flow (CBF, % contralateral hemisphere by laser-Doppler flowmetry), and survival (%) were examined 24 hours after the initial ischemic event. Adoptive transfer studies used 111In-labeled PMNs (from either CD18 +/+ or CD18 -/- mice) to examine the relative accumulation of PMNs in the ischemic region.
ResultsPMNs obtained from CD18 -/- mice exhibit reduced adhesivity (compared with CD18 +/+ PMNs) for both quiescent and cytokine-activated endothelial monolayers. CD18 -/- mice (n=14) subjected to transient focal cerebral ischemia demonstrated a 53% decrease in infarct volumes versus CD18 +/+ mice (n=26, P<0.05), improved penumbral CBF at 24 hours (1.8-fold, P=0.02), and a 3.7-fold decrease in mortality (P=0.02). However, when CD18 -/- mice (n=12) were subjected to permanent focal cerebral ischemia, no differences were noted in infarct volume, mortality, or CBF versus similarly treated CD18 +/+ mice (n=10). There was a greater accumulation of CD18 +/+ PMNs in the ischemic zone of CD18 +/+ animals than CD18 -/- animals subjected to reperfused stroke (82% increase, P=0.02), although there was no difference between groups when subjected to permanent MCA occlusion.
ConclusionsDeficiency for the CD18 gene confers cerebral protection in a murine model of reperfused stroke, but this benefit does not extend to CD18-deficient animals subjected to permanent MCA occlusion. These data suggest that anti-PMN strategies should be targeted to reperfused stroke and may perhaps be used in conjunction with thrombolytic therapy that establishes reperfusion.
Cardiovascular Disease Research, DuPont Pharmaceuticals Company, Wilmington, Delaware
This article has been cited by other articles:
![]() |
J. Neumann, S. Sauerzweig, R. Ronicke, F. Gunzer, K. Dinkel, O. Ullrich, M. Gunzer, and K. G. Reymann Microglia Cells Protect Neurons by Direct Engulfment of Invading Neutrophil Granulocytes: A New Mechanism of CNS Immune Privilege J. Neurosci., June 4, 2008; 28(23): 5965 - 5975. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Terao, G. Yilmaz, K. Y. Stokes, M. Ishikawa, T. Kawase, and D. N. Granger Inflammatory and Injury Responses to Ischemic Stroke in Obese Mice Stroke, March 1, 2008; 39(3): 943 - 950. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Gidday, Y. G. Gasche, J.-C. Copin, A. R. Shah, R. S. Perez, S. D. Shapiro, P. H. Chan, and T. S. Park Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H558 - H568. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Rane, D. Gozal, W. Butt, E. Gozal, W. M. Pierce Jr, S. Z. Guo, R. Wu, A. D. Goldbart, V. Thongboonkerd, K. R. McLeish, et al. {gamma}-Amino Butyric Acid Type B Receptors Stimulate Neutrophil Chemotaxis during Ischemia-Reperfusion J. Immunol., June 1, 2005; 174(11): 7242 - 7249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishikawa, T. Vowinkel, K. Y. Stokes, T. V. Arumugam, G. Yilmaz, A. Nanda, and D. N. Granger CD40/CD40 Ligand Signaling in Mouse Cerebral Microvasculature After Focal Ischemia/Reperfusion Circulation, April 5, 2005; 111(13): 1690 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Nicholls, G. J. Dusting, B. Cutri, S. Bao, G. R. Drummond, K.-A. Rye, and P. J. Barter Reconstituted High-Density Lipoproteins Inhibit the Acute Pro-Oxidant and Proinflammatory Vascular Changes Induced by a Periarterial Collar in Normocholesterolemic Rabbits Circulation, March 29, 2005; 111(12): 1543 - 1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Arumugam, J. W. Salter, J. H. Chidlow, C. M. Ballantyne, C. G. Kevil, and D. N. Granger Contributions of LFA-1 and Mac-1 to brain injury and microvascular dysfunction induced by transient middle cerebral artery occlusion Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2555 - H2560. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Sughrue, E. S. Connolly Jr, M. Krams, K. R. Lees, W. Hacke, A. P. Grieve, J.-M. Orgogozo, and G. A. Ford Effectively Bridging the Preclinical/Clinical Gap: The Results of the ASTIN Trial * Response Stroke, April 1, 2004; 35(4): e81 - e82. [Full Text] [PDF] |
||||
![]() |
K. Dinkel, F. S. Dhabhar, and R. M. Sapolsky Neurotoxic effects of polymorphonuclear granulocytes on hippocampal primary cultures PNAS, January 6, 2004; 101(1): 331 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cherian, G. J. Hankey, J. W. Eikelboom, J. Thom, R. I. Baker, A. McQuillan, J. Staton, and Q. Yi Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiological Subtypes Stroke, September 1, 2003; 34(9): 2132 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, Z. G. Zhang, R. L. Zhang, M. Lu, M. Krams, and M. Chopp Effects of a Selective CD11b/CD18 Antagonist and Recombinant Human Tissue Plasminogen Activator Treatment Alone and in Combination in a Rat Embolic Model of Stroke Stroke, July 1, 2003; 34(7): 1790 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mocco, T. Choudhri, J. Huang, E. Harfeldt, L. Efros, C. Klingbeil, V. Vexler, W. Hall, Y. Zhang, W. Mack, et al. HuEP5C7 as a Humanized Monoclonal Anti-E/P-Selectin Neurovascular Protective Strategy in a Blinded Placebo-Controlled Trial of Nonhuman Primate Stroke Circ. Res., November 15, 2002; 91(10): 907 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J.M. Frijns and L.J. Kappelle Inflammatory Cell Adhesion Molecules in Ischemic Cerebrovascular Disease Stroke, August 1, 2002; 33(8): 2115 - 2122. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kubes, D. Payne, and R. C. Woodman Molecular mechanisms of leukocyte recruitment in postischemic liver microcirculation Am J Physiol Gastrointest Liver Physiol, July 1, 2002; 283(1): G139 - G147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Campanella, C. Sciorati, G. Tarozzo, and M. Beltramo Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain Stroke, February 1, 2002; 33(2): 586 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, D. B. Agus, C. J. Winfree, S. Kiss, W. J. Mack, R. A. McTaggart, T. F. Choudhri, L. J Kim, J Mocco, D. J. Pinsky, et al. Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke PNAS, September 25, 2001; 98(20): 11720 - 11724. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Huang, T. F. Choudhri, C. J. Winfree, R. A. McTaggart, S. Kiss, J. Mocco, L. J. Kim, T. S. Protopsaltis, Y. Zhang, D. J. Pinsky, et al. Postischemic Cerebrovascular E-Selectin Expression Mediates Tissue Injury in Murine Stroke Editorial Comment Stroke, December 1, 2000; 31(12): 3047 - 3053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Ginsberg On Ischemic Brain Injury in Genetically Altered Mice Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2581 - 2583. [Full Text] [PDF] |
||||
![]() |
J. Huang, L. J. Kim, R. Mealey, H. C. Marsh Jr., Y. Zhang, A. J. Tenner, E. S. Connolly Jr., and D. J. Pinsky Neuronal Protection in Stroke by an sLex-Glycosylated Complement Inhibitory Protein Science, July 23, 1999; 285(5427): 595 - 599. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |